Tests and diagnosisBy Mayo Clinic Staff
Diagnosing Barrett's esophagus
Endoscopy is generally used to determine if you have Barrett's esophagus.
A lighted tube with a camera at the end (endoscope) is passed down your throat to check for signs of changing esophagus tissue. Normal esophagus tissue appears pale and glossy. In Barrett's esophagus, the tissue appears red and velvety.
Your doctor is likely to remove a small tissue sample (biopsy). The biopsy can be examined to determine the degree of tissue change.
Determining the degree of tissue change
A doctor who specializes in examining tissue in a laboratory (pathologist) determines the degree of dysplasia in your esophagus cells. Your tissue may be classified as:
Aug. 07, 2014
- No dysplasia, if Barrett's esophagus is present but no precancerous changes are found in the cells.
- Low-grade dysplasia, if cells show small signs of precancerous changes.
- High-grade dysplasia, if cells show many changes. High-grade dysplasia is thought to be the final step before cells change into esophageal cancer.
- Spechler SJ, et al. Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus. http://www.uptodate.com/home. Accessed Jan. 25, 2014.
- Feldman M, et al. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 9th ed. Philadelphia, Pa.: Saunders Elsevier; 2010. http://www.clinicalkey.com. Accessed Jan. 25, 2014.
- Spechler SJ, et al. Management of Barrett's esophagus. http://www.uptodate.com/home. Accessed Jan. 25, 2014.
- Ferri FF. Ferri's Clinical Advisor 2014: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2014. https://www.clinicalkey.com. Accessed Jan. 25, 2014.
- AskMayoExpert. Who should be screened for Barrett esophagus? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2012.
- Estores D, et al. Barrett Esophagus: Epidemiology, pathogenesis, diagnosis, and management. Current Problems in Surgery. 2013;50:192.
- Nelsen EM, et al. Diagnosis and management of Barrett's esophagus. Surgical Clinics of North America. 2012;92:1135.
- Gorospe EC, et al. Risk stratification and surveillance in Barrett's esophagus. Nature Reviews Gastroenterology & Hepatology. In press. Accessed Jan. 25, 2014.
- Spechler SJ, et al. Pathogenesis of Barrett's esophagus and its malignant transformation. http://www.uptodate.com/home. Accessed Jan. 25, 2014.
- Qumseya BJ, et al. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: A meta-analysis and systematic review. Clinical Gastroenterology and Hepatology. 2013;11:1562.
- Bergman JJ, et al. Radiofrequency ablation for Barrett's esophagus. http://www.uptodate.com/home. Accessed Jan. 25, 2014.
- Tomizawa Y, et al. Assessment of the diagnostic performance and interobserver variability of endocytoscopy in Barrett's esophagus: A pilot ex-vivo study. World Journal of Gastroenterology. 2013;19:8652.
- Ek WE, et al. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. Journal of the National Cancer Institute. 2013;105:1711.
- Barrett's Esophagus. National Institute of Diabetes and Digestive and Kidney Diseases. http://digestive.niddk.nih.gov/ddiseases/pubs/barretts/index.aspx. Accessed Jan. 28, 2014.